Materials and methods for treating coagulation disorders

   
   

This invention is drawn to compounds which are more easily metabolized by the metabolic drug detoxification systems. Particularly, warfarin analogs which have been designed to include esters within the structure of the compounds are taught. The invention teaches methods of reducing the toxicity of drugs comprising the introduction of ester groups into drugs during the synthesis of the drug. This invention is also drawn to methods of treating coagulation disorders comprising the administration of compounds which have been designed to be metabolized by serum or intracellular hydrolases and esterases. Pharmaceutical compositions of the ester containing warfarin, analogs are also taught.

Esta invenção é extraída aos compostos que metabolized mais fàcilmente pelos sistemas metabolic do detoxification da droga. Particularmente, os analogs do warfarin que foram projetados incluir esters dentro da estrutura dos compostos são ensinados. A invenção ensina métodos de reduzir o toxicity das drogas que compreendem a introdução de grupos do ester em drogas durante a síntese da droga. Esta invenção é extraída também aos métodos de tratar os disorders do coagulation que compreendem a administração dos compostos que foram projetados metabolized pelo serum ou hydrolases e esterases intracellular. As composições pharmaceutical do ester que contem o warfarin, analogs são ensinadas também.

 
Web www.patentalert.com

< Benzo[4,5]thieno[2,3-c]pyridine and Benzo[4,5]furo[2,3-c]pyridine Derivatives Useful as Inhibitors of Phosphodiesterase

< Cardiovascular support control system

> Phospholipid-coated implants

> Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

~ 00167